We are live on ! Find out more
GTC

Ghost Tree Capital Portfolio holdings

AUM $331M
1-Year Est. Return 70.11%
This Fund
S&P 500
This Quarter Est. Return
+10.06%
1 Year Est. Return
+70.11%
3 Year Est. Return
+265.05%
5 Year Est. Return
+3,034.98%
10 Year Est. Return
+22,104.75%
AUM
$278M
AUM Growth
+$69.7M
Cap. Flow
+$59.7M
Cap. Flow %
21.48%
Top 10 Hldgs %
34.47%
Holding
97
New
38
Increased
13
Reduced
9
Closed
33

Top Buys

1
ZSPH
ZS PHARMA INC COMS TK (DE)
ZSPH
+$7.55M
2
CYH icon
Community Health Systems
CYH
+$7.52M
3
CELG
Celgene Corp
CELG
+$7.17M
4
MRK icon
Merck
MRK
+$5.93M
5
SAGE
Sage Therapeutics
SAGE
+$5.16M

Top Sells

1
GILD icon
Gilead Sciences
GILD
+$6.13M
2
LJPC
La Jolla Pharmaceutical Company
LJPC
+$5.28M
3
ASRT
Assertio
ASRT
+$4.83M
4
NVRO
NEVRO CORP.
NVRO
+$4.45M
5
INSY
Insys Therapeutics, Inc.
INSY
+$4.22M

Sector Composition

1 Healthcare 71.61%
2 Technology 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LOXO
51
DELISTED
Loxo Oncology, Inc
LOXO
$2.18M 0.78%
+175,000
New +$2.18M
EPZM
52
DELISTED
Epizyme, Inc
EPZM
$2.16M 0.78%
+115,000
New +$2.37M
BDSI
53
CALL
DELISTED
BioDelivery Sciences International, Inc.
BDSI
$2.1M 0.76%
+200,000
New +$2.73M
EIGR
54
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
$1.89M 0.68%
222
+133
+149% +$1.16M
ADXS
55
DELISTED
Advaxis Inc
ADXS
$1.8M 0.65%
8,333
-19,874
-70% -$3.06M
UNIS
56
DELISTED
Unilife Corporation
UNIS
$1.8M 0.65%
+45,000
New +$1.8M
PODD icon
57
Insulet
PODD
$11.4B
$1.67M 0.6%
+50,000
New +$1.69M
ASMB icon
58
Assembly Biosciences
ASMB
$531M
$1.66M 0.6%
10,417
+5,000
+92% +$676K
KIN
59
DELISTED
Kindred Biosciences, Inc.
KIN
$718K 0.26%
+100,500
New +$693K
BIOL
60
DELISTED
Biolase, Inc.
BIOL
$606K 0.22%
24
– –
OCRX
61
DELISTED
Ocera Therapeutics, Inc.
OCRX
$589K 0.21%
125,000
– –
GBIM
62
DELISTED
GLOBEIMMUNE INC COM STK (DE)
GBIM
$506K 0.18%
68,973
+45,473
+194% +$329K
XOMA
63
DELISTED
Xoma
XOMA
$262K 0.09%
+3,600
New +$264K
ARAY icon
64
Accuray
ARAY
$30.8M
– –
-300,000
Closed -$2.27M
ASRT
65
DELISTED
Assertio
ASRT
– –
-5,000
Closed -$4.83M
ATRC icon
66
AtriCure
ATRC
$1.77B
– –
-100,000
Closed -$2M
BHC icon
67
Bausch Health
BHC
$1.8B
– –
-20,000
Closed -$2.86M
CPRX icon
68
Catalyst Pharmaceutical
CPRX
– –
-250,000
Closed -$743K
GILD icon
69
CALL
Gilead Sciences
GILD
$167B
– –
-125,000
Closed -$11.8M
GILD icon
70
Gilead Sciences
GILD
$167B
– –
-65,000
Closed -$6.13M
IONS icon
71
CALL
Ionis Pharmaceuticals
IONS
$8.99B
– –
-150,000
Closed -$9.26M
IONS icon
72
PUT
Ionis Pharmaceuticals
IONS
$8.99B
– –
-50,000
Closed -$3.09M
ISRG icon
73
Intuitive Surgical
ISRG
$122B
– –
-36,000
Closed -$2.12M
QDEL icon
74
QuidelOrtho
QDEL
$1.19B
– –
-100,000
Closed -$2.89M
SNN icon
75
Smith & Nephew
SNN
$12.9B
– –
-30,000
Closed -$1.1M
1 2
3
4

Similar funds

SF
Susquehanna Foundation Bala Cynwyd, Pennsylvania $333M AUM 35.73% 1-Year Est. Return
AFS
Annapolis Financial Services Annapolis, Maryland $338M AUM 23.49% 1-Year Est. Return
SFA
Source Financial Advisors New York $338M AUM 33.62% 1-Year Est. Return
E
ETFidea Syracuse, New York $316M AUM 29.57% 1-Year Est. Return
OHCM
Oak Hill Capital Management New York $310M AUM 17.23% 1-Year Est. Return
MC
Minot Capital Broomfield, Colorado $353M AUM 25.25% 1-Year Est. Return
BRA
Biechele Royce Advisors Fishers, Indiana $303M AUM 20.64% 1-Year Est. Return
S
Syntrinsic Denver, Colorado $301M AUM 27.27% 1-Year Est. Return

Ghost Tree Capital's Q1 2015 Portfolio in Review

As of Q1 2015, Ghost Tree Capital held 97 positions worth $278M, up 33% from $208M the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Ghost Tree Capital deployed $59.7M of net new capital in Q1 2015, opening 38 new positions and adding to 13 existing holdings. Its largest new stake was ZS PHARMA INC COMS TK (DE): 165,000 shares worth $6.94M.

By sector, the portfolio is most concentrated in Healthcare at 72% of assets, up from 69% a quarter earlier, followed by Technology.

On the sell side, the largest reduction was Advaxis Inc, an estimated $3.06M trimmed.

  • Ghost Tree Capital's largest Q1 2015 buy was ZS PHARMA INC COMS TK (DE): 165,000 shares worth $6.94M.
  • Ghost Tree Capital added most to Allergan plc in Q1 2015, an estimated $4.99M increase.
  • Ghost Tree Capital's biggest Q1 2015 reduction was Advaxis Inc, cutting an estimated $3.06M.
  • Ghost Tree Capital fully exited Gilead Sciences in Q1 2015, selling an estimated $6.13M.
  • Ghost Tree Capital's ten largest holdings make up 34% of its $278M portfolio in Q1 2015.
  • Ghost Tree Capital opened 38 new positions and closed 33 in Q1 2015.
  • Ghost Tree Capital's portfolio value rose 33% quarter-over-quarter to $278M.

Based on Ghost Tree Capital's 13F filing for Q1 2015, filed 15 May 2015.